October 2016

In recognition of his work in cancer research and his efforts to further the development of oncologic imaging and interventional oncology, Professor Jean-François Geschwind has been invited by the European Society of Radiology to deliver the Wilhelm Conrad Röntgen Honorary Lecture, entitled ‘Interventional oncology: the era of molecular targeted therapy’ at ECR 2013.

Jean-François Geschwind is professor of radiology, surgery, and oncology, and director of the division of vascular and interventional radiology at the Johns Hopkins University School of Medicine in Baltimore, Maryland/US. He is also director of the Interventional Radiology Center and chief of interventional radiology research at the Johns Hopkins Hospital.

Originally from France, Prof. Geschwind began his early medical training at the University of Paris School of Medicine and subsequently moved to the United States, where he studied at the University of Pennsylvania and then completed his medical degree at Boston University School of Medicine in Massachusetts. He completed his residency training in diagnostic radiology as a research scholar (sponsored by the National Institutes of Health) at the University of California, San Francisco in 1996. He went on to complete his two-year training in vascular and interventional radiology at the Johns Hopkins University School of Medicine, before joining the faculty there as an assistant professor. In 2002, he was appointed director of the division of vascular and interventional radiology and the Interventional Radiology Center at Johns Hopkins Hospital, and in 2007 he was promoted to professor of radiology, surgery and oncology at the Johns Hopkins University School of Medicine.

A leading figure in the field of liver cancer, Prof. Geschwind has focused most of his research on hepatic cancer. He has received numerous grants from foundations, industry and the federal government for his research in the field.

Prof. Geschwind has authored or co-authored more than 350 scientific articles and abstracts on interventional radiology and, more specifically, the treatment of liver cancer. As lead or co-investigator on more than 40 clinical trials, Dr. Geschwind’s research has been published in highly rated peer-reviewed journals, including the Journal of Clinical Oncology, Clinical Cancer Research, Radiology, European Radiology, Gastroenterology and Annals of Surgery. He has also won numerous national and international awards in recognition of his research accomplishments. In addition to having co-authored the first book dedicated to interventional radiology, entitled Interventional Oncology: Principles and Practice, Prof. Geschwind is currently co-editing the book, Abrams Angiography: Interventional Radiology with Dr. Michael Dake.

A prolific speaker and lecturer, both nationally and internationally, Prof. Geschwind has delivered over 200 keynote speeches at scientific assemblies, annual meetings and symposia. He has also served as visiting professor at many prestigious institutions throughout the world.